NORTHERN TRUST CORP - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 35 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$28,020
-24.1%
44,4760.0%0.00%
Q2 2023$36,915
+88.6%
44,4760.0%0.00%
Q1 2023$19,569
-25.4%
44,4760.0%0.00%
Q4 2022$26,236
-15.4%
44,4760.0%0.00%
Q3 2022$31,000
-51.6%
44,4760.0%0.00%
Q2 2022$64,000
-61.7%
44,4760.0%0.00%
Q1 2022$167,000
-51.9%
44,4760.0%0.00%
Q4 2021$347,00044,4760.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
First PREMIER Bank 807,535$4760.14%
Warberg Asset Management LLC 370,370$218,5180.03%
METEORA CAPITAL, LLC 134,524$79,3560.02%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 149,774$88,3520.02%
SILVER OAK SECURITIES, INCORPORATED 51,941$310.01%
Veritable, L.P. 506,513$298,7920.01%
Shaolin Capital Management LLC 236,621$1400.00%
Elgethun Capital Management 14,796$9,1710.00%
LGL PARTNERS, LLC 23,000$13,5680.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$49,5520.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders